Discovery of pyrimidyl-5-hydroxamic acids as new potent histone deacetylase inhibitors.
暂无分享,去创建一个
M. Janicot | L. van Hijfte | H. De Winter | Laurence Quéguiner | A. Aerts | J. Arts | P. Angibaud | E. Freyne | I. Pilatte | V. Poncelet | J. van Dun | M. Verdonck | J. van Gompel | W. Floren | B. Janssens | K. van Emelen | Sandrine Gaurrand | J. Argoullon | Bruno Roux | A. Marien | Sven van Brandt | P. ten Holte | Jacky van Gompel
[1] A. Ho,et al. Role of histone deacetylase inhibitors in the treatment of cancer (Review). , 2004, International journal of oncology.
[2] M. Esteller,et al. Histone deacetylase inhibitors: Understanding a new wave of anticancer agents , 2004, International journal of cancer.
[3] N. L. La Thangue,et al. Histone deacetylase inhibitors open new doors in cancer therapy. , 2004, Biochemical pharmacology.
[4] S. Izraeli,et al. Histone deacetylase inhibitors--a new tool to treat cancer. , 2004, Cancer treatment reviews.
[5] P. Workman,et al. Histone modification enzymes: novel targets for cancer drugs. , 2004, Expert Opinion on Emerging Drugs.
[6] Vigushin Dm,et al. Targeted histone deacetylase inhibition for cancer therapy. , 2004 .
[7] K. Glaser,et al. Histone deacetylase inhibitors: the Abbott experience. , 2003, Current medicinal chemistry.
[8] A. V. van Kuilenburg,et al. Histone deacetylases (HDACs): characterization of the classical HDAC family. , 2003, The Biochemical journal.
[9] Ettore Novellino,et al. Specific targeting of acetylcholinesterase and butyrylcholinesterase recognition sites. Rational design of novel, selective, and highly potent cholinesterase inhibitors. , 2003, Journal of medicinal chemistry.
[10] P. Marks,et al. Histone deacetylase inhibitors: from target to clinical trials , 2002, Expert opinion on investigational drugs.
[11] Ricky W. Johnstone,et al. Histone-deacetylase inhibitors: novel drugs for the treatment of cancer , 2002, Nature Reviews Drug Discovery.
[12] M. Jung,et al. Inhibitors of histone deacetylase as new anticancer agents. , 2001, Current medicinal chemistry.
[13] M. Yoshida,et al. Mechanism of cell cycle arrest caused by histone deacetylase inhibitors in human carcinoma cells. , 2000, The Journal of antibiotics.
[14] Wen‐Ming Yang,et al. Histone Deacetylases Specifically Down-regulate p53-dependent Gene Activation* , 2000, The Journal of Biological Chemistry.
[15] G Brosch,et al. Amide analogues of trichostatin A as inhibitors of histone deacetylase and inducers of terminal cell differentiation. , 1999, Journal of medicinal chemistry.
[16] S. Meng,et al. p21WAF1 is required for butyrate-mediated growth inhibition of human colon cancer cells , 1998 .
[17] I. Forbes,et al. An Efficient Synthesis of a-Carboline-3-carboxylic Acid, Ethyl Ester (a-CCE) , 1993 .
[18] Matty P. Weijenberg,et al. A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer , 2002, Nature Genetics.
[19] Vigushin Dm,et al. Histone deacetylase inhibitors in cancer treatment. , 2002 .